Circadian clock function does not require the histone methyltransferase MLL3.
KMT2C
MLL3
circadian
clock
epigenetics
histone
inflammation
methyltransferase
Journal
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
revised:
26
04
2022
received:
14
03
2022
accepted:
06
05
2022
entrez:
15
6
2022
pubmed:
16
6
2022
medline:
18
6
2022
Statut:
ppublish
Résumé
The circadian clock controls the physiological function of tissues through the regulation of thousands of genes in a cell-type-specific manner. The core cellular circadian clock is a transcription-translation negative feedback loop, which can recruit epigenetic regulators to facilitate temporal control of gene expression. Histone methyltransferase, mixed lineage leukemia gene 3 (MLL3) was reported to be required for the maintenance of circadian oscillations in cultured cells. Here, we test the role of MLL3 in circadian organization in whole animals. Using mice expressing catalytically inactive MLL3, we show that MLL3 methyltransferase activity is in fact not required for circadian oscillations in vitro in a range of tissues, nor for the maintenance of circadian behavioral rhythms in vivo. In contrast to a previous report, loss of MLL3-dependent methylation did not affect the global levels of H3K4 methylation in liver, indicating substantial compensation from other methyltransferases. Furthermore, we found little evidence of genomic repositioning of H3K4me3 marks. We did, however, observe repositioning of H3K4me1 from intronic regions to intergenic regions and gene promoters; however, there were no changes in H3K4me1 mark abundance around core circadian clock genes. Output functions of the circadian clock, such as control of inflammation, were largely intact in MLL3-methyltransferase-deficient mice, although some gene-specific changes were observed, with sexually dimorphic loss of circadian regulation of specific cytokines. Taken together, these observations indicate that MLL3-directed histone methylation is not essential for core circadian clock function; however, it may influence the inflammatory response.
Identifiants
pubmed: 35704036
doi: 10.1096/fj.202200368R
pmc: PMC9328146
doi:
Substances chimiques
Histone Methyltransferases
EC 2.1.1.-
Histone-Lysine N-Methyltransferase
EC 2.1.1.43
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e22356Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N002024/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 107851/Z/15/2
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 107849/Z/15/Z
Pays : United Kingdom
Informations de copyright
© 2022 The Authors. The FASEB Journal published by Wiley Periodicals LLC on behalf of Federation of American Societies for Experimental Biology.
Références
Mol Cell. 2012 Oct 26;48(2):277-87
pubmed: 22981862
Science. 2012 Oct 19;338(6105):349-54
pubmed: 22936566
Immunology. 2020 Dec;161(4):261-267
pubmed: 31820826
Nat Struct Mol Biol. 2010 Dec;17(12):1414-21
pubmed: 21113167
Nat Genet. 2017 Nov;49(11):1647-1653
pubmed: 28967912
FASEB J. 2021 Oct;35(10):e21843
pubmed: 34464475
Genes Dev. 2020 Nov 1;34(21-22):1493-1502
pubmed: 33033055
Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15240-5
pubmed: 20696890
Mol Endocrinol. 2005 Jun;19(6):1452-9
pubmed: 15761026
Mol Cell. 2017 May 18;66(4):568-576.e4
pubmed: 28483418
J Clin Invest. 2018 Jun 1;128(6):2281-2296
pubmed: 29533925
Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1554-9
pubmed: 23297224
FASEB J. 2022 Jul;36(7):e22356
pubmed: 35704036
Mol Cell. 2019 Nov 21;76(4):531-545.e5
pubmed: 31706703
Proc Natl Acad Sci U S A. 2020 Oct 13;117(41):25869-25879
pubmed: 32989157
Mol Cell Biol. 2013 Dec;33(23):4745-54
pubmed: 24081332
Science. 2017 Sep 1;357(6354):912-916
pubmed: 28860383
Nucleic Acids Res. 2018 Apr 20;46(7):3382-3399
pubmed: 29447387
Mol Endocrinol. 2001 Feb;15(2):241-54
pubmed: 11158331
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
J Clin Invest. 2018 Oct 1;128(10):4454-4471
pubmed: 30179226
J Reprod Immunol. 2006 Aug;71(1):12-27
pubmed: 16574244
Nat Struct Mol Biol. 2006 Aug;13(8):713-9
pubmed: 16878130
Proc Natl Acad Sci U S A. 2012 Jan 10;109(2):582-7
pubmed: 22184247
Infect Immun. 2001 Oct;69(10):6119-22
pubmed: 11553550
Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15392-7
pubmed: 17021013
Nature. 2003 Jan 9;421(6919):177-82
pubmed: 12483227
Genes Dev. 2012 Dec 1;26(23):2604-20
pubmed: 23166019
Prog Mol Biol Transl Sci. 2009;87:343-82
pubmed: 20374709
Genome Biol. 2008;9(9):R137
pubmed: 18798982
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Cell. 2013 Dec 19;155(7):1464-78
pubmed: 24360271
Mol Cell Biol. 2004 Jul;24(14):6278-87
pubmed: 15226430
Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19229-34
pubmed: 19047629
Nat Med. 2014 Aug;20(8):919-26
pubmed: 25064128
Cell Rep. 2016 Dec 6;17(10):2715-2723
pubmed: 27926873
Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5339-46
pubmed: 14963227
Nucleic Acids Res. 2019 Jan 8;47(D1):D729-D735
pubmed: 30462313
Sci Rep. 2016 Jul 21;6:29983
pubmed: 27439882
Development. 2012 Jul;139(14):2500-9
pubmed: 22675208
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W187-91
pubmed: 24799436
F1000Res. 2018 Aug 24;7:1338
pubmed: 30254741
Curr Protoc Bioinformatics. 2014 Sep 08;47:11.12.1-34
pubmed: 25199790
Transgenic Res. 1999 Aug;8(4):265-77
pubmed: 10621974
Nat Commun. 2018 Aug 20;9(1):3323
pubmed: 30127461
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Brief Bioinform. 2013 Mar;14(2):178-92
pubmed: 22517427
Nat Genet. 2018 Jan;50(1):73-82
pubmed: 29255264